Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed CFO Acq. announced Director departure Quarterly results Appointed director CC transcript
|
ILLUMINA, INC. (ILMN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/02/2021 |
GN
| Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services |
01/11/2021 |
GN
| Myriad Genetics Forms Strategic Partnership with Illumina in Oncology |
09/24/2019 |
GN
| Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx |
10/11/2018 |
GN
| Analysis: Positioning to Benefit within Tenet Healthcare, GAIN Capital, Illumina, First Cash, Regis, and Cornerstone OnDemand — Research Highlights Growth, Revenue, and Consolidated Results |
08/06/2018 |
GN
| Detailed Research: Economic Perspectives on Allete, Sterling Construction, Illumina, PROS, Altra Industrial Motion, and Pacific Biosciences of California — What Drives Growth in Today's Competitive Landscape |
06/12/2018 |
GN
| Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation |
04/10/2018 |
GN
| Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics |
02/14/2018 |
GN
| New Research Coverage Highlights Illumina, Vectren, Chemours, Fastenal, Norwegian Cruise Line, and Globalstar — Consolidated Revenues, Company Growth, and Expectations for 2018 |
11/30/2017 |
GN
| Market Trends Toward New Normal in Illumina, Vectren, Chemours, Fastenal, Norwegian Cruise Line, and Globalstar — Emerging Consolidated Expectations, Analyst Ratings |
10/24/2017 |
GN
| Analysis: Positioning to Benefit within Becton, Dickinson and Company, FedEx, Ulta Beauty, Alliance Data Systems, Illumina, and Arista Networks – Research Highlights Growth, Revenue, and Consolidated Results |
06/28/2017 |
GN
| Adamas Appoints New Chief Financial Officer |
03/07/2017 |
GN
| OPKO Subsidiary GenPath Women's Health Announces the Availability of ClariTest™ |
02/28/2017 |
GN
| OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day |
02/28/2017 |
GN
| OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day |
02/13/2017 |
GN
| DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ILMN |
02/13/2017 |
GN
| DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) & Lead Plaintiff Deadline: February 14, 2017 |
|
|